Follow
James C. Geoghegan
James C. Geoghegan
Adimab
Verified email at adimab.com
Title
Cited by
Cited by
Year
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler, MK Sutherland, JC Geoghegan, C Yu, T Hayes, JE Skonier, ...
The EMBO journal, 2003
13642003
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
CG Rappazzo, LV Tse, CI Kaku, D Wrapp, M Sakharkar, D Huang, ...
Science 371 (6531), 823-829, 2021
2842021
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation
MK Sutherland, JC Geoghegan, C Yu, E Turcott, JE Skonier, DG Winkler, ...
Bone 35 (4), 828-835, 2004
2822004
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids
NR Deleault, JR Piro, DJ Walsh, F Wang, J Ma, JC Geoghegan, ...
Proceedings of the National Academy of Sciences 109 (22), 8546-8551, 2012
2652012
Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions
NR Deleault, JC Geoghegan, K Nishina, R Kascsak, RA Williamson, ...
Journal of Biological Chemistry 280 (29), 26873-26879, 2005
2512005
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins
DG Winkler, MSK Sutherland, E Ojala, E Turcott, JC Geoghegan, ...
Journal of Biological Chemistry 280 (4), 2498-2502, 2005
1982005
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex
DG Winkler, C Yu, JC Geoghegan, EW Ojala, JE Skonier, D Shpektor, ...
Journal of Biological Chemistry 279 (35), 36293-36298, 2004
1742004
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
M Sakharkar, CG Rappazzo, WF Wieland-Alter, CL Hsieh, D Wrapp, ...
Science immunology 6 (56), eabg6916, 2021
1672021
Selective incorporation of polyanionic molecules into hamster prions
JC Geoghegan, PA Valdes, NR Orem, NR Deleault, RA Williamson, ...
Journal of biological chemistry 282 (50), 36341-36353, 2007
1382007
Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro
NR Deleault, R Kascsak, JC Geoghegan, S Supattapone
Biochemistry 49 (18), 3928-3934, 2010
1132010
Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action
JC Geoghegan, G Diedrich, X Lu, K Rosenthal, KF Sachsenmeier, H Wu, ...
MAbs 8 (3), 454-467, 2016
1112016
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts
MK Sutherland, JC Geoghegan, C Yu, DG Winkler, JA Latham
Bone 35 (2), 448-454, 2004
1072004
Analgesic effectiveness of transversus abdominis plane blocks after hysterectomy: a meta-analysis
R Champaneria, L Shah, J Geoghegan, JK Gupta, JP Daniels
European Journal of Obstetrics & Gynecology and Reproductive Biology 166 (1 …, 2013
1062013
Cancelled operations: a 7-day cohort study of planned adult inpatient surgery in 245 UK National Health Service hospitals
DJN Wong, SK Harris, SR Moonesinghe, SR Moonesinghe, DJN Wong, ...
British journal of anaesthesia 121 (4), 730-738, 2018
932018
Short Hairpin RNA–Mediated Inhibition of Matrix Metalloproteinase-1 in MDA-231 Cells: Effects on Matrix Destruction and Tumor Growth
CA Wyatt, JC Geoghegan, CE Brinckerhoff
Cancer research 65 (23), 11101-11108, 2005
902005
Cell salvage at caesarean section: the need for an evidence‐based approach
J Geoghegan, JP Daniels, PAS Moore, PJ Thompson, KS Khan, ...
BJOG: An International Journal of Obstetrics & Gynaecology 116 (6), 743-747, 2009
832009
Copper (II) ions potently inhibit purified PrPres amplification
NR Orem, JC Geoghegan, NR Deleault, R Kascsak, S Supattapone
Journal of neurochemistry 96 (5), 1409-1415, 2006
722006
Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO)
KS Khan, PAS Moore, MJ Wilson, R Hooper, S Allard, I Wrench, ...
PLoS Medicine 14 (12), e1002471, 2017
682017
Trans-Dominant Inhibition of Prion Propagation In Vitro Is Not Mediated by an Accessory Cofactor
JC Geoghegan, MB Miller, AH Kwak, BT Harris, S Supattapone
PLoS pathogens 5 (7), e1000535, 2009
682009
Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering
JC Geoghegan, R Fleming, M Damschroder, SM Bishop, HA Sathish, ...
MAbs 8 (5), 941-950, 2016
662016
The system can't perform the operation now. Try again later.
Articles 1–20